Du är här


myoscience: myoscience, inc. is a Finalist for the 2014 Red Herring Top 100 North America Award

REDWOOD CITY, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- California based myoscience, inc., makers of the revolutionary iovera° system for treatment of peripheral nerves, announced today it has been selected as a finalist for Red Herring's Top 100 North America award, a prestigious list honoring the year's most promising private technology ventures from the North American business region.Red Herring has been selecting the most exciting and promising start-ups and
"scale ups" since 1995. Finalists are still evaluated individually from a
large pool of hundreds of candidates based across North America. Twenty major
criteria underlie the scoring and process. The list of finalists often
includes the best performing and prominent companies of that year.

"We are honored to be recognized as a finalist for this award," said
myoscience CEO Clint Carnell. "I'm proud to see the efforts of our talented
employees recognized. Their hard-work and dedication the past 9 years
bringing this remarkable platform technology to the world will change the
landscape of treating peripheral nerve conditions."

Myoscience's groundbreaking iovera° treatment harnesses the power of cold with
the Focused Cold TherapyTMdelivery system and delivers immediate results for
both therapeutic and aesthetic applications. The iovera° treatment does not
use toxins, chemicals, or pharmaceuticals to achieve results and leaves
nothing behind in the body. The iovera° system is FDA cleared for the
treatment of pain in the United States and is approved in the European Union
and Canada for the treatment of wrinkles.

2014 will be remembered as a special vintage. "The finalists list confirms the
excellent choices made by entrepreneurs and VCs and the start-ups' solid
roots in corporate America, embracing their innovations. By all metrics, it
emphasizes the United States' entrepreneurial excellence," said Alex Vieux,
publisher and CEO of Red Herring.

Finalists are asked to present their winning strategies at the Red Herring
North America Forum in Monterey, Calif., May 14 to 16, 2014. The Top 100
winners will be announced at a special awards ceremony the evening of May 16
at the event.

Please follow the Red Herring conference
athttps://twitter.com/digitalherringhashtag #RedHerring100


Silicon Valley, California-based myoscience is a privately-held medical device
company committed to making its platform technology, Focused Cold Therapy,
the standard of care for the treatment of peripheral nerve conditions.
Focused Cold Therapy is the patented technology delivered by the iovera
system. The iovera° system is currently approved in Europe and Canada for
temporary wrinkle reduction, temporary pain reduction and treatment of
dermatologic conditions, and is indicated in the United States for use in
pain management and general surgical use. For more information, please visit

The myoscience logo is available

© 2014 myoscience. All rights reserved. iovera° and Focused Cold Therapy are
trademarks of myoscience.

CONTACT: 1600 Seaport Blvd., Ste. 450 / Redwood City, CA
Tel: 650.474.2600 / iovera.com

Jay Patel / jay.patel@hypertonic.com


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: myoscience via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.